Dec 07 2025
Silver (XAG) Forecast: Price Prediction Points Higher if Fed Confirms 2026 Rate Cuts
Vaalco Energy: Cash Flow Update
UIVM: Unconvincing Blend Of Value And Momentum
ATYR DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
The Cut Countdown
MLTX Deadline: MLTX Investors with Losses in Excess of $100K Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
DEFT UPCOMING DEADLINE: Faruqi & Faruqi Reminds In DeFi Technologies Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 30, 2026 - DEFT
FLY DEADLINE: Faruqi & Faruqi Reminds Firefly Aerospace Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 - FLY
STUB DEADLINE: Faruqi & Faruqi Reminds StubHub Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 23, 2026 - STUB
VICI Properties: The Drop I Anticipated Arrived (Rating Upgrade)
The Market Is Giving Investors an Unbeatable Opportunity to Buy This Long-Term Artificial Intelligence (AI) Winner (Hint: Not Palantir or Nvidia)
KMX DEADLINE: Faruqi & Faruqi Reminds Baxter International Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 2, 2026 - KMX
GitLab Shares Plunge. Why It May Be Time to Load Up on the Stock Ahead of the New Year.
Victoria's Secret: The Brand Is Regaining Momentum
FCX DEADLINE: Faruqi & Faruqi Reminds Freeport-McMoran Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 - FCX
Capricor: Maintaining 'Hold' Rating On Randomized Phase 3 HOPE-3 Trial Win With Deramiocel
BTDR DEADLINE: Faruqi & Faruqi Reminds Bitdeer Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 2, 2026 - BTDR
AVTR DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor
Palantir Crushes 63% Growth While UiPath Celebrates Its First Profit
BAX DEADLINE: Faruqi & Faruqi Reminds Baxter International Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - BAX
Costco Holds Steady While Walmart Bets Big on E-Commerce Transformation
Top Wall Street analysts favor these 3 stocks for their growth potential
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
OWL DEADLINE: Faruqi & Faruqi Reminds Blue Owl Capital Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 2, 2026 - OWL
Victoria's Secret: The Reasons Why The Post-Earnings Rally Is Not Justified
Grocers See Increasing Evidence That Consumers Are Feeling More Strain
ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodgkin Lymphoma, at ASH Annual Meeting
US Stormwater Management Market Size Worth USD 15.05 Billion by 2033 | SNS Insider
BST: Technology Options CEF With 7.3% Yield, Growth, No Leverage, But Volatility
Yescarta® Delivers Consistent Safety, Efficacy, and Quality of Life Benefits Across Broad Range of Relapsed/Refractory Large B-cell Lymphoma Patients in New Analysis at ASH 2025
Oil-Dri Corporation of America: Upside Hasn't Dried Up Yet
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma
Silver Price Forecast – ETF Inflows and Supply Deficits Set Stage for $100 Surge in 2026
The Trade Desk Is In War Mode
The Generational Shift I See Now - And My 33 Stocks For What's Coming
ARE INVESTOR LOSSES: Lose Money on Alexandria Real Estate Equities, Inc.? Contact BFA Law before January 26 Securities Class Action Deadline
KMX INVESTOR LOSSES: Lose Money on CarMax, Inc.? Contact BFA Law before January 2 Securities Class Action Deadline
INSP INVESTOR LOSSES: Lose Money on Inspire Medical Systems, Inc.? Contact BFA Law before January 5 Securities Class Action Deadline
FCX INVESTOR LOSSES: Lose Money on Freeport-McMoRan Inc.? Contact BFA Law before January 12 Securities Class Action Deadline
JEF INVESTOR LOSSES: Lose Money on Jefferies Financial Group Inc.? Contact BFA Law about its Securities Fraud Investigation
SNPS INVESTOR LOSSES: Lose Money on Synopsys, Inc.? Contact BFA Law before December 30 Securities Class Action Deadline
MLTX INVESTOR LOSSES: Lose Money on MoonLake Immunotherapeutics? Contact BFA Law before December 15 Securities Class Action Deadline
LRN INVESTOR LOSSES: Lose Money on Stride, Inc.? Contact BFA Law before January 12 Securities Class Action Deadline
JHX INVESTOR LOSSES: Lose Money on James Hardie Industries plc? Contact BFA Law before December 23 Securities Class Action Deadline
Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy?
Evaluating Nio Stock's Actual Performance
Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting
Why Carvana (CVNA) stock is rocketing
TSMC: Foundry Monopoly, Inelastic Demand, Robust Pricing Power, And Cheap Valuations
AeroVironment Is On Sale: Modern Defense Runs On Drones, Not Tanks
Credo Technology Stock Is Soaring. Is This a Top AI Play for 2026?
QDVO: A Positive Scenario For 2026
Arcellx, Inc. (ACLX) Discusses Phase 2 iMMagine-1 Study Results and Multiple Myeloma Treatment Advances Transcript
Doximity: Elite Margins, AI Growth, And An Attractive Multiple
UP Fintech Q3: Structural Growth And Strong Profitability
3 Reasons Why Rocket Lab Stock Is A Millionaire-Maker
The Best High-Yield Dividend ETF to Invest $1,000 In Right Now
3 Top Artificial Intelligence Stocks to Buy in December
Commvault Systems: AI Data Trends And Strong SaaS Growth
Sea: A Puzzling Dip And A Tremendous Buying Opportunity
Microsoft: Path To $600
Why Nvidia and Other AI Stocks Have Lost Their ‘Quality' Status
What to Expect in Markets This Week: Fed Interest Rate Decision and Powell Remarks; Earnings From Oracle, Broadcom
Why I'm Buying Duolingo Stock Like There's No Tomorrow
Here's Why USA Rare Earth Stock Crashed in November
How Good Has RH Stock Actually Been?
I Let Reddit Choose My Wedding Dress — and They Got It Right
Prediction: These 3 Stocks Could Be Worth More Than Apple 3 Years From Now
Has Roblox (RBLX) Stock Been Good for Investors?
Credo Technology Just Proved It's an AI "Picks-and-Shovels" Stock Worth Watching
Hims & Hers: The Market's Panic Is Irrational
SoundHound AI Stock Is Down 36% in 2025. Where Could It Be at the End of 2026?
DigitalOcean's $1B AI Signal Implies Strong Inflection (Rating Upgrade)
Where Will Robinhood Stock Be in 1 Year?
Should You Buy Rigetti Computing Stock After Its 2,750% Gain Since 2024? Wall Street Has a Surprising Answer.
CLOI: Low Potential For Revaluation
PWB: Growth Is Now More Appealing
FinVolution: Cheap, Consistent, And Expanding Abroad
WPAY Vs. YMAX: Don't Let The 69% Yield Fool You
LiveWorld (OTCMKTS:LVWD) & Genius Sports (NYSE:GENI) Head to Head Survey
Comparing SOPHiA GENETICS (NASDAQ:SOPH) and Azenta (NASDAQ:AZTA)
Financial Comparison: Passage Bio (NASDAQ:PASG) versus PepGen (NASDAQ:PEPG)
Analyzing Robin Energy (NASDAQ:RBNE) and Costamare (NYSE:CMRE)
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
Japanese Yen Weekly Forecast: USD/JPY Eyes 150 as Fed Decision Looms
Inomin Mines (CVE:MINE) Trading Up 20% – Still a Buy?
M&G (LON:MNG) Sets New 1-Year High – Here’s Why
Spanish Mountain Gold (CVE:SPA) Stock Price Down 14.8% – Time to Sell?
Spanish Mountain Gold (CVE:SPA) Shares Down 14.8% – What’s Next?
Spanish Mountain Gold (CVE:SPA) Trading Down 14.8% – Should You Sell?
Tullow Oil (LON:TLW) Shares Down 10.5% – Time to Sell?
Spanish Mountain Gold (CVE:SPA) Stock Price Down 14.8% – Should You Sell?
Aztec Minerals (CVE:AZT) Shares Down 13.8% – Time to Sell?
Spanish Mountain Gold (CVE:SPA) Shares Down 14.8% – Here’s What Happened
UBS may cut further 10,000 jobs by 2027, SonntagsBlick reports
Is Alnylam Pharmaceuticals a Millionaire Maker?
Gold (XAUUSD) Price Forecast: Markets Brace for Volatility as FOMC Looms
Silver (XAG) Forecast: Silver Rally Accelerates on PCE Data and Fed Policy Hopes
Chewy: Priced For Perfection While Competition Heats Up
Cenovus Energy: Buying Scale, Boosting Returns, And Still Undervalued
Risk Disclosure:Derivatives are traded over-the-counter on margin, which means they carry a high level of risk and there is a possibility you could lose all of your investment. These products are not suitable for all investors. Please ensure you fully understand the risks and carefully consider your financial situation and trading experience before trading. Seek independent financial advice if necessary before opening an account with BCR.
BCR Co Pty Ltd (Company No. 1975046) is a company incorporated under the laws of the British Virgin Islands, with its registered office at Trident Chambers, Wickham’s Cay 1, Road Town, Tortola, British Virgin Islands, and is licensed and regulated by the British Virgin Islands Financial Services Commission under License No. SIBA/L/19/1122.
Open Bridge Limited (Company No. 16701394) is a company incorporated under the Companies Act 2006 and registered in England and Wales, with its registered address at Kemp House, 160 City Road, London, City Road, London, England, EC1V 2NX. This entity acts solely as a payment processor and does not provide any trading or investment services.